RedHill Biopharma
About:
RedHill Biopharma specializes primarily in gastrointestinal and infectious diseases within the realm of specialty biopharmaceuticals.
Website: http://www.redhillbio.com
Twitter/X: RedHillBio
Top Investors: OrbiMed, Nomura, H. C. Wainwright & Co., Biomedical Advanced Research and Development Authority (BARDA), ROTH Capital Partners
Description:
RedHill Biopharma specializes in the field of gastrointestinal and infectious diseases, constituting its primary areas of focus within the realm of specialty biopharmaceuticals. It focuses on advancing gastrointestinal and infectious diseases management through innovation, dedication, and a collective mindset of delivering on its promises.
$275M
$10M to $50M
Tel Aviv, Tel Aviv, Israel
2009-01-01
info(AT)redhillbio.com
Dror Ben-Asher, Ori Shilo
101-250
2024-10-14
Public
© 2025 bioDAO.ai